PER
Click for more information
1.18% 8.4¢ percheron therapeutics limited

atl1103 successfully progresses towards phase

  1. Trade4Profit88
    9,784 Posts.
    lightbulb Created with Sketch. 621
    clock Created with Sketch.
    07/12/11
    10:00
    Post #: 9402583
    ATL1103 Successfully Progresses Towards Phase II Clinical Trial

    ATL1103 Phase I trial successfully meets primary endpoint – safe and well
    tolerated
    ? Preliminary indication of drug activity shown with reduction of serum IGF-I
    and other markers of drug activity
    ? Next step is a Phase II trial in patients with the growth disorder,
    acromegaly
    ANP Price at posting: 32.0¢ Sentiment: ST Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RZI https://hotcopper.com.au/news/asx-news/149063/fast-track-assaying-yields-182-g-t-gold-for-itech-at-new-nt-play/
right-arrow Created with Sketch.
SXE SCEE boosts Synergy deal by $50M for Collie battery project
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
STN Saturn’s stars have aligned for the gold explorer’s Apollo Project
right-arrow Created with Sketch.
NEWS Finding properties tenants will want to rent
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢ 		Change
-0.001(1.18%) 		Mkt cap ! $75.72M
Open High Low Value Volume
8.4¢ 8.4¢ 8.3¢ $3.097K 37.23K

Buyers (Bids)

No. Vol. Price($)
1 29206 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 118557 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.